How important is it to understand the natural history of disease before embarking on drug development? Annette Stemhagen of United BioSource Corporation discusses. Having an in-depth understanding ...

But now the FDA has rubber-stamped the approval of Luxturna, the first ever gene therapy it has backed, all the attention is now on Spark, and what price it plans to charge for the therapy.

It is possible for the FDA to make the pick for flu shots without consulting the panel, a former federal health official said, though it would be unprecedented in recent history. The panel often ...

The U.S. Food and Drug Administration’s (FDA) chief counsel resigned two days after her appointment, according to a Thursday announcement from the agency. “Hilary K. Perkins has resigned from ...